How many acquisitions has Lilly made so far?

Lilly has completed 40 acquisitions so far, with an average acquisition amount of $1.73B.

Which countries does Lilly usually acquire in?

Lilly has made acquisitions in 6 countries with the most activity in United States and United Kingdom.

Which sectors does Lilly target for acquisitions?

Most of Lilly's acquisitions are in Oncology (13) and Neurology (10).

List of 40 Acquisitions by Lilly (Oct 2026)

Q: Which is Lilly's latest acquisition?

Lilly's most recent acquisition is Meridabio, a Developer of targeted therapies for autoimmune and allergic disorders, acquired in August 2026.

Most viewed in 2019

Lilly has made a total of 40 acquisitions. These acquisitions span 27 sectors, including Oncology, Neurology, and Immunotherapy, across 6 countries, with the highest volume in United States, United Kingdom, and Canada. Peak years for acquisitions were 2026 with 11, 2023 with 6, and 2025 with 3. The average number of acquisitions per year from 2020 to 2025 is 2.8, and 11 acquisitions have been completed in the current year. The most recent acquisition is Meridabio, a Cambridge-based developer of targeted therapies for autoimmune and allergic disorders founded in 2019, which was acquired in August 2026.

Here's the year on year acquisition history of Lilly:

Number of Total Acquisitions

Year	# Acquisitions
2026	11
2025	3
2024	2
2023	6
2022	2
2021	1
2020	3
2019	1
2018	2
2017	1
2016	1
2014	1
2011	1
2010	2
2008	2
2007	1

View all Acquisitions by Lilly

Recent acquisitions by Lilly

Lilly's most recent acquisition - Meridabio is a Developer of targeted therapies for autoimmune and allergic disorders, founded in 2019 and located in Cambridge. Lilly acquired it in August 2026 for a price of $*****.

Here is the list of all acquisitions by Lilly sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Aug 31, 2026	Meridabio	zapn	keht	33	254
Jul 16, 2026	AtaiBeckley	vehm	ybey	76	845
Jun 16, 2026	4E Therapeutics	gpdv	nbvm	41	239
May 26, 2026	LimmaTech Biologics	yfg{	nwli	48	684
May 20, 2026	Engage Bio	qysc	dm{n	27	868